PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Duke University Medical Center, Durham (United States of America)
4 More presentations in this session
Doctor M. Vaduganathan (Boston, US)
Doctor M. Kosiborod (Kansas City, US)
Doctor R. Campbell (Glasgow, GB)
Professor A. Voors (Groningen, NL)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
You may be interested in
Congress Presentation
Congress Session
